BE opens Rs 300-crore vaccine plant near Hyderabad

Hyderabad: Telangana IT Minister KT Rama Rao on Monday inaugurated Biological E. Limited's (BE) new plant and unveiled its new Typhoid Conjugate Vaccine (TCV).

BE built the new plant at Rs300-crore investment in the Special Economic Zone (SEZ) at Genome Valley in Kolthur Village on the outskirts of Hyderabad.

While appreciating the expansion initiatives of Biological E Ltd, KTR said: "We are committed to making the Telangana a number one State in terms of industrial growth and employment generation with a special focus on life sciences.

In fact, these growth engines will not only boost the economy of the state, but also improve the livelihood of people, who depend directly or indirectly on these industries.

We are happy to see that this massive state-of-the-art plant, the foundation stone for which was laid during BioAsia-2017, is getting inaugurated during this 17th edition of BioAsia today."

Mahima Datla, MD, Biological E. Ltd, adds: "BE has invested around Rs300 crore for building this plant, which is now ready for commercial production, on about 29 acres of land.

This plant would generate employment opportunities for around 1,000 people. This new facility will help our existing vaccines plant enhance the production and manufacture new products, which are in the pipeline."

Recently, BE received the authorisation from the health regulatory authorities of India to license and market a new typhoid conjugate vaccine.